1392 related articles for article (PubMed ID: 10945503)
1. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.
Romerio F; Riva A; Zella D
Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503
[TBL] [Abstract][Full Text] [Related]
2. MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b.
Romerio F; Zella D
FASEB J; 2002 Oct; 16(12):1680-2. PubMed ID: 12206994
[TBL] [Abstract][Full Text] [Related]
3. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
[TBL] [Abstract][Full Text] [Related]
4. cAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner.
Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
Oncogene; 2002 Sep; 21(39):6101-12. PubMed ID: 12203122
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
6. Thrombin-stimulated cell proliferation mediated through activation of Ras/Raf/MEK/MAPK pathway in canine cultured tracheal smooth muscle cells.
Lin CC; Shyr MH; Chien CS; Wang CC; Chiu CT; Hsiao LD; Yang CM
Cell Signal; 2002 Mar; 14(3):265-75. PubMed ID: 11812655
[TBL] [Abstract][Full Text] [Related]
7. MEK1/2-ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes.
Xiao L; Pimental DR; Amin JK; Singh K; Sawyer DB; Colucci WS
J Mol Cell Cardiol; 2001 Apr; 33(4):779-87. PubMed ID: 11273730
[TBL] [Abstract][Full Text] [Related]
8. ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma.
Hu J; Roy SK; Shapiro PS; Rodig SR; Reddy SP; Platanias LC; Schreiber RD; Kalvakolanu DV
J Biol Chem; 2001 Jan; 276(1):287-97. PubMed ID: 10995751
[TBL] [Abstract][Full Text] [Related]
9. P2Y(2) receptor-mediated proliferation of C(6) glioma cells via activation of Ras/Raf/MEK/MAPK pathway.
Tu MT; Luo SF; Wang CC; Chien CS; Chiu CT; Lin CC; Yang CM
Br J Pharmacol; 2000 Apr; 129(7):1481-9. PubMed ID: 10742305
[TBL] [Abstract][Full Text] [Related]
10. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
11. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.
Park JI; Strock CJ; Ball DW; Nelkin BD
Mol Cell Biol; 2003 Jan; 23(2):543-54. PubMed ID: 12509453
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression.
Guha M; O'Connell MA; Pawlinski R; Hollis A; McGovern P; Yan SF; Stern D; Mackman N
Blood; 2001 Sep; 98(5):1429-39. PubMed ID: 11520792
[TBL] [Abstract][Full Text] [Related]
13. Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy.
Tong Z; Singh G; Rainbow AJ
Cancer Res; 2002 Oct; 62(19):5528-35. PubMed ID: 12359764
[TBL] [Abstract][Full Text] [Related]
14. Tumour necrosis factor-alpha enhances bradykinin-induced signal transduction via activation of Ras/Raf/MEK/MAPK in canine tracheal smooth muscle cells.
Hsu YM; Chiu CT; Wang CC; Chien CS; Luo SF; Hsiao LD; Liang KY; Yang CM
Cell Signal; 2001 Sep; 13(9):633-43. PubMed ID: 11495721
[TBL] [Abstract][Full Text] [Related]
15. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration.
Rajalingam K; Wunder C; Brinkmann V; Churin Y; Hekman M; Sievers C; Rapp UR; Rudel T
Nat Cell Biol; 2005 Aug; 7(8):837-43. PubMed ID: 16041367
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors.
Zhang J; Lodish HF
Blood; 2004 Sep; 104(6):1679-87. PubMed ID: 15166036
[TBL] [Abstract][Full Text] [Related]
17. Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929.
Huang WC; Chio CC; Chi KH; Wu HM; Lin WW
Exp Cell Res; 2002 Jul; 277(2):192-200. PubMed ID: 12083801
[TBL] [Abstract][Full Text] [Related]
18. Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis.
Wu J; Wong WW; Khosravi F; Minden MD; Penn LZ
Cancer Res; 2004 Sep; 64(18):6461-8. PubMed ID: 15374955
[TBL] [Abstract][Full Text] [Related]
19. Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells.
Watters JJ; Chun TY; Kim YN; Bertics PJ; Gorski J
Mol Endocrinol; 2000 Nov; 14(11):1872-81. PubMed ID: 11075818
[TBL] [Abstract][Full Text] [Related]
20. Anti-leukemia effect of perillyl alcohol in Bcr/Abl-transformed cells indirectly inhibits signaling through Mek in a Ras- and Raf-independent fashion.
Clark SS; Zhong L; Filiault D; Perman S; Ren Z; Gould M; Yang X
Clin Cancer Res; 2003 Oct; 9(12):4494-504. PubMed ID: 14555523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
